LOGIN
Kashin-Beck disease: Chondroitin sulfate plus Glucosamine reduces pain and stiffness
August 2013
Kashin-Beck disease: Chondroitin sulfate plus Glucosamine reduces pain and stiffness
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study
Osteoarthritis Cartilage. 2012 Jul;20(7):622-9. Epub 2012 Mar 30.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
251 patients with Kashin-Beck disease (KBD) were randomized to receive oral administration of either chondroitin sulfate, glucosamine hydrochloride, a combination of chondroitin sulfate and glucosamine hydrochloride, or a placebo. The results following 6 months of treatment indicate that the combined treatment of chondroitin sulfate and glucosamine hydrochlroide is more effective in providing KBD ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.